Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
04/2014
04/24/2014US20140113856 Magnesium Compositions for Modulating the Pharmacokinetics and Pharmacodynamics of Insulin and Insulin Analogs, and Injection Site Pain
04/24/2014US20140113821 Polysaccharide-based hydrogel polymer and uses thereof
04/24/2014US20140113818 Sophorolactone compositions and uses thereof
04/24/2014US20140113371 Cryopreservation of Haptenized Tumor Cells
04/24/2014US20140113009 Controlled application of cross-linking agent
04/24/2014US20140112991 Topical steroid composition and method
04/24/2014US20140112980 Abuse-resistant pharmaceutical compositions
04/24/2014US20140112979 Methods for producing liposomes
04/24/2014US20140112977 Allogeneic autophagosome-enriched composition for the treatment of disease
04/24/2014US20140112975 Lipid-Conjugated Rhamnose for Immune System Recruitment and Oncotherapy
04/24/2014US20140112962 Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant
04/24/2014US20140112960 Visible light curable hydrogels and methods for using
04/24/2014US20140112959 Topical steroid composition and method
04/24/2014US20140112944 Compositions and methods for treating cancer
04/24/2014US20140112943 Method of developing a vaccine using peptide-poly ic complexes
04/24/2014US20140112902 Methods for treatment of inflammatory and infectious diseases
04/24/2014US20140112901 Stable compositions containing thrombin and methods for preparation and use thereof
04/24/2014US20140112900 Solubilized CoQ-10
04/24/2014US20140112881 Crosslinked polymer nano-assemblies and uses thereof
04/24/2014US20140112880 Subcutaneous delivery of poly(oxazoline) polymer conjugates
04/24/2014US20140112874 Tape-type fluorine preparation using biodegradable polymer and method of preparing the same
04/24/2014US20140112873 Melanocortin 1 receptor ligands and methods of use
04/24/2014US20140110297 "Medical Articles Coated With Organopolysiloxane Containing a Protein Solution"
04/24/2014US20140109916 Transdermal Delivery of Hormones without the Need of Penetration Enhancers
04/24/2014DE102012105512A1 Arzneiform zur verlängerten Freisetzung von Wirkstoffen Dosage form for the prolonged release of active ingredients
04/24/2014DE102012020392A1 Pigmente Pigments
04/23/2014EP2722060A2 Guanylyl cyclase C ligands
04/23/2014EP2722053A1 Antibacterial agent for treating infectious diseases of bacterial origin
04/23/2014EP2722051A1 Monomethylvaline compounds having phenylalanine side-chain modifications at the C-terminus
04/23/2014EP2722040A1 Lidocaine-containing cataplasm
04/23/2014EP2722035A1 Aqueous pharmaceutical compositions containing borate-polyol complexes
04/23/2014EP2721062A1 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
04/23/2014EP2720999A1 Novel lipidomimetic compounds and uses thereof
04/23/2014EP2720723A1 Stabilized voriconazole composition
04/23/2014EP2720722A1 Multi-vinylsulfone containing molecule
04/23/2014EP2720686A1 Multi-layer capsule and manufacture method thereof
04/23/2014EP2720684A2 A sustained-release composition containing peptides as active ingredient
04/23/2014EP2720680A1 Inhalable pharmaceutical compositions
04/23/2014CN103748142A Reversibly crosslinked micelle systems
04/23/2014CN103748139A Micro- or nanoparticles comprising a biodegradable polyesteramide copolymer for use in the delivery of bioactive agents
04/23/2014CN103748115A Highly functional cellulose composite
04/23/2014CN103747807A P97-antibody conjugates and methods of use
04/23/2014CN103747806A Non-peptidyl polymer-insulin multimer and method for producing same
04/23/2014CN103747805A New compounds for treating, delaying and/or preventing human genetic disorder such as myotonic dystrophy type 1 (DMI)
04/23/2014CN103747804A Protein-polymer-drug conjugates
04/23/2014CN103747792A Delivery of viral agents
04/23/2014CN103747780A Aqueous solutions of lipophilic substances, in particular medicinal solutions
04/23/2014CN103747771A Encapsulates
04/23/2014CN103743898A Phosphorylcholine conjugates and corresponding antibodies
04/23/2014CN103740648A Kinesin spindle protein (Eg5) monoclonal antibody and hybridoma cell strain secreting it
04/23/2014CN103739853A Metal organic coordination polymer nanowire cluster and preparation method thereof
04/23/2014CN103739764A Magnetic macroporous adsorption resin microspheres, and preparation method thereof
04/23/2014CN103739714A TNF alpha and DC-SIGN fusion protein and application thereof
04/23/2014CN103739712A Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life
04/23/2014CN103739688A Liquorice protein nanoparticles and preparation method thereof
04/23/2014CN103739673A Polyethyleneglycol-modified polypeptide capable of inhibiting interleukin-6 and application thereof
04/23/2014CN103739671A Polyethyleneglycol-modified polypeptide capable of inhibiting nuclear factor-kappaB and application thereof
04/23/2014CN103739670A Polyethylene glycol modified polypeptide for inhibiting tumor necrosis factor-alpha and application of polypeptide
04/23/2014CN103739639A Stevioside A glycoside crystal and preparation method and application thereof
04/23/2014CN103739549A Preparation and application of naphthalimide-amino acid compound and modified quantum dot
04/23/2014CN103736201A Radioactive particle chain
04/23/2014CN103736104A Nano-material based on up-conversion luminescence as well as preparation method and application thereof
04/23/2014CN103736101A Preparation method of pH value-sensitive curcumin-loading micelle (single chain) precursor
04/23/2014CN103736100A Novel microbicide anhydride modified anti-SEVI (semen-derived enhancer of viral infection) polyclonal antibody for preventing HIV (human immunodeficiency virus) sexual transmission
04/23/2014CN103736099A Prodrug with nitrophenyl alkyl acid connected with alkaline antitumor drugs and preparation method thereof
04/23/2014CN103736098A Intranasal medicinal composition containing bilastine and mometasone furoate
04/23/2014CN103736097A PH and temperature supersensitive dendrimer drug carrier (generation 2.5) and preparation method thereof
04/23/2014CN103736096A Composition containing paclitaxel and preparation method thereof
04/23/2014CN103736089A Human diploid cell cultured rabies vaccine and preparation method thereof
04/23/2014CN103736079A Vegetable oil body gel containing EGF (Epidermal Growth Factor)
04/23/2014CN103736078A mPEG (Ethyl Glycolate)-HM-3 polypeptide lyophilized powder injection preparation as well as preparation method and application thereof
04/23/2014CN103736039A Chewable tablet beneficial to cold prevention
04/23/2014CN103735817A Flavored composition for treating cold
04/23/2014CN103735815A Controlled-release composition for cold
04/23/2014CN103735814A Composition used for cold
04/23/2014CN103735688A Refined traditional Chinese medicine composition for ginseng and astragalus yang warming vaginal expansion suppository as well as expansion suppository and preparation method thereof
04/23/2014CN103735629A Controlled-release composition for cough
04/23/2014CN103735617A Compound red sage root orally-disintegrating tablet and preparation method thereof
04/23/2014CN103735616A Microencapsulated preparation for protecting eyesight and preparation method thereof
04/23/2014CN103735601A Herba orostachyos vaginal expansion suppository as well as preparation method and detection method thereof
04/23/2014CN103735590A Flavor composition for hot cold
04/23/2014CN103735589A Composition for treating pyretic cold
04/23/2014CN103735581A Care solution for cleaning nasal cavity and preparation method of care solution
04/23/2014CN103735567A Composite hemostatic spray
04/23/2014CN103735547A Metronidazole-clotrimazole-chlorhexidine acetate vaginal expansive suppository controlled-release preparation and preparation method thereof
04/23/2014CN103735544A Preparing process for vildagliptin/metformin hydrochloride compound preparation
04/23/2014CN103735540A Calcium gluconate aqueous solution with high calcium content and preparation method thereof
04/23/2014CN103735536A Total cucurbitacin phosphatidyl cholate mixed micelle oral quick-absorption membrane and preparation method thereof
04/23/2014CN103735535A Preparation method of polyamino acid-based hydrogel microcapsule
04/23/2014CN103735533A Organic and inorganic compound nano-capsule agent and preparation method thereof
04/23/2014CN103735532A Lutein ester microcapsule and preparation method thereof
04/23/2014CN103735531A Preparation method for microcapsules with magnetic nanoparticles-containing capsule walls
04/23/2014CN103735528A Trimetazidine hydrochloride bi-layer osmotic pump controlled release tablet and preparation method thereof
04/23/2014CN103735526A Omeprazole magnesium enteric-coated tablet and manufacturing method thereof
04/23/2014CN103735525A Dapoxetine tablets and preparation method thereof
04/23/2014CN103735522A Andrographolide freeze-dried powder and preparation method thereof
04/23/2014CN103735520A Phloroglucinol granules and preparation method thereof
04/23/2014CN103735519A Deferasirox granules and preparation method thereof
04/23/2014CN103735518A Preparation method of timolol maleate sustained release microspheres
04/23/2014CN103735517A Microspheres including oxidized cellulose
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 1712